State-of-the-art

Rheumatoid arthritis

Iain B. McInnes, James Robert O'Dell

Research output: Contribution to journalReview article

199 Citations (Scopus)

Abstract

The understanding of the pathogenesis and optimal therapeutics for rheumatoid arthritis (RA) has advanced remarkably over the last decade. This review highlights these key advances, particularly the outcomes of genome-wide scans which have provided an increasingly robust appraisal of the complex genetics that underpin RA. Such observations are placed in pathogenetic context, particularly concerning the breach of tolerance that presages synovitis and the mechanisms that subserve chronicity. The key therapeutic strategies and treatment agents, both conventional and biological, now available to effectively manage the disease are described. Throughout the review, emphasis is placed on unanswered questions and challenges in this exciting field.

Original languageEnglish (US)
Pages (from-to)1898-1906
Number of pages9
JournalAnnals of the Rheumatic Diseases
Volume69
Issue number11
DOIs
StatePublished - Nov 1 2010

Fingerprint

Rheumatoid Arthritis
Synovitis
Genes
Genome
Therapeutics
Genetics

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

State-of-the-art : Rheumatoid arthritis. / McInnes, Iain B.; O'Dell, James Robert.

In: Annals of the Rheumatic Diseases, Vol. 69, No. 11, 01.11.2010, p. 1898-1906.

Research output: Contribution to journalReview article

McInnes, Iain B. ; O'Dell, James Robert. / State-of-the-art : Rheumatoid arthritis. In: Annals of the Rheumatic Diseases. 2010 ; Vol. 69, No. 11. pp. 1898-1906.
@article{ad3ebd62421343febb1d933de8bedf1b,
title = "State-of-the-art: Rheumatoid arthritis",
abstract = "The understanding of the pathogenesis and optimal therapeutics for rheumatoid arthritis (RA) has advanced remarkably over the last decade. This review highlights these key advances, particularly the outcomes of genome-wide scans which have provided an increasingly robust appraisal of the complex genetics that underpin RA. Such observations are placed in pathogenetic context, particularly concerning the breach of tolerance that presages synovitis and the mechanisms that subserve chronicity. The key therapeutic strategies and treatment agents, both conventional and biological, now available to effectively manage the disease are described. Throughout the review, emphasis is placed on unanswered questions and challenges in this exciting field.",
author = "McInnes, {Iain B.} and O'Dell, {James Robert}",
year = "2010",
month = "11",
day = "1",
doi = "10.1136/ard.2010.134684",
language = "English (US)",
volume = "69",
pages = "1898--1906",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "11",

}

TY - JOUR

T1 - State-of-the-art

T2 - Rheumatoid arthritis

AU - McInnes, Iain B.

AU - O'Dell, James Robert

PY - 2010/11/1

Y1 - 2010/11/1

N2 - The understanding of the pathogenesis and optimal therapeutics for rheumatoid arthritis (RA) has advanced remarkably over the last decade. This review highlights these key advances, particularly the outcomes of genome-wide scans which have provided an increasingly robust appraisal of the complex genetics that underpin RA. Such observations are placed in pathogenetic context, particularly concerning the breach of tolerance that presages synovitis and the mechanisms that subserve chronicity. The key therapeutic strategies and treatment agents, both conventional and biological, now available to effectively manage the disease are described. Throughout the review, emphasis is placed on unanswered questions and challenges in this exciting field.

AB - The understanding of the pathogenesis and optimal therapeutics for rheumatoid arthritis (RA) has advanced remarkably over the last decade. This review highlights these key advances, particularly the outcomes of genome-wide scans which have provided an increasingly robust appraisal of the complex genetics that underpin RA. Such observations are placed in pathogenetic context, particularly concerning the breach of tolerance that presages synovitis and the mechanisms that subserve chronicity. The key therapeutic strategies and treatment agents, both conventional and biological, now available to effectively manage the disease are described. Throughout the review, emphasis is placed on unanswered questions and challenges in this exciting field.

UR - http://www.scopus.com/inward/record.url?scp=78149492075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149492075&partnerID=8YFLogxK

U2 - 10.1136/ard.2010.134684

DO - 10.1136/ard.2010.134684

M3 - Review article

VL - 69

SP - 1898

EP - 1906

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 11

ER -